DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. Financials - Benzinga

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd.

DSKYFOTCPK

Trade with Public

Trade with Public

$18.25

0.00750.04%

At close: Aug 25, 5:00 PM EST

Overview NewsFinancialsSentiment Ownership Compare

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. Financials

DAIICHI SANKYO CO LTD ORD by Daiichi Sankyo Co., Ltd. (DSKYF) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

Merck's Q2 Earnings: Revenue And EPS Beat Helped By Strong Keytruda Sales, But Acquisition Costs Bites Into Annual Profit Forecast

Merck reports Q2 sales of $16.1 billion, a 7% increase YoY, beating estimates. Keytruda sales surged 16% to $7.27 billion. FDA approvals for Capvaxive and Winrevair highlight the quarter. Merck revises 2024 sales guidance to $63.4B-$64.4B.

Vandana Singh

The Daily Biotech Pulse: FDA Tentatively Approves Avadel's Narcolepsy Drug, European Approval Broadens AstraZeneca's Enhertu in Breast Cancer, Pharma Giants' Earnings

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

The Daily Biotech Pulse: AstraZeneca's 3 Product Updates, Jazz Pharma Licenses Sleeping Disorder Product, Argenx Aces Bleeding Disorder Study

Here's a roundup of top developments in the biotech space over the last 24 hours:

Vandana Singh

The Daily Biotech Pulse: Molecular Partners Plunges On Double Bad News, Pfizer/BioNTech Seek Nod For COVID-19 Shot In Kids, Pfizer Invests In Zentalis

Here's a roundup of top developments in the biotech space over the last 24 hours.

Vandana Singh

Esperion Chops 40% Workforce As Launch Of Cholesterol Medication Falters

Esperion Therapeutics Inc's (NASDAQ: ESPR) cholesterol drug marketing strategy has soured badly, as it has been struggling to sell its heart disease pill for more than a year.

Vandana Singh

Earnings Roundup

Benzinga